NDC 61755-005 – Eylea

Aflibercept 40 mg/mL · Injection, Solution · Intravitreal

Human Prescription Drug 2 recalls

Product NDC61755-005

Product details

Brand name
Eylea
Generic name
Aflibercept
Labeler
Regeneron Pharmaceuticals, Inc.
Dosage form
Injection, Solution
Route
Intravitreal
Marketing category
BLA · BLA125387
Marketed since
November 21, 2011
Listing expires
December 31, 2027
Pharmacologic class
Vascular Endothelial Growth Factor Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Eylea →

Package NDC codes (4)

Package NDCDescriptionSince
61755-005-011 SYRINGE, GLASS in 1 CARTON (61755-005-01) / .05 mL in 1 SYRINGE, GLASSDec 9, 2019
61755-005-021 VIAL, SINGLE-USE in 1 CARTON (61755-005-02) / .05 mL in 1 VIAL, SINGLE-USENov 21, 2011
61755-005-541 SYRINGE, GLASS in 1 CARTON (61755-005-54) / .05 mL in 1 SYRINGE, GLASSDec 9, 2019
61755-005-551 VIAL, SINGLE-USE in 1 CARTON (61755-005-55) / .05 mL in 1 VIAL, SINGLE-USEJan 16, 2014

Recalls mentioning this NDC